LYT-200 now has gained fast track designation from the FDA in acute myeloid leukemia in addition to its prior designation for recurrent or metastatic head and neck squamous cell carcinoma. The FDA has ...

We interviewed three optometrists, two eyeglasses providers, two sleep specialists, a medical doctor, and an ergonomics expert. And we enlisted a panel of three testers to try 13 different pairs.

(RTTNews) - Biotherapeutics company PureTech Health plc (PRTC) announced Thursday that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to LYT-200, a first-in-class ...